CD8A and neoplasm: A study conducted in a mouse model showed that FMT could significantly enhance the therapeutic efficacy of ICIs in syngeneic tumor models by increasing tumor-infiltrating IFN-γ+CD8+ T cells and the tumor suppression effect (135).